Enveric Biosciences Stock (NASDAQ:ENVB), Quotes and News Summary

Q: What sector and industry does Enveric Biosciences (ENVB) operate in?

Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Enveric Biosciences Stock (NASDAQ: ENVB) stock price, news, charts, stock research, profile.

Open	$0.930
Close	$0.895
Volume / Avg.	58.269K / 4.312M
Day Range	0.892 - 0.945
52 Wk Range	0.649 - 6.980
Market Cap	$6.638M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	3.52%
Days to Cover	1

Recent News

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More

Lara Goldstein

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday.

Avi Kapoor

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Enveric Biosciences Inc

Sector

Health Care

Industry

Pharmaceuticals

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplasto...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Enveric Biosciences (ENVB) stock?

You can purchase shares of Enveric Biosciences (NASDAQ: ENVB) through any online brokerage.

View our list of the best stock brokerages.

Who are Enveric Biosciences's (ENVB) competitors?

Other companies in Enveric Biosciences’s space includes: Cingulate (NASDAQ:CING), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Palisade Bio (NASDAQ:PALI) and Hepion Pharmaceuticals (NASDAQ:HEPA).

What is the target price for Enveric Biosciences (ENVB) stock?

The latest price target for Enveric Biosciences (NASDAQ: ENVB) was reported by HC Wainwright & Co. on Tuesday, January 30, 2024. The analyst firm set a price target for 10.00 expecting ENVB to rise to within 12 months (a possible 998.90% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Enveric Biosciences (ENVB)?

The stock price for Enveric Biosciences (NASDAQ: ENVB) is $0.91 last updated April 26, 2024 at 6:15 PM EDT.

Does Enveric Biosciences (ENVB) pay a dividend?

There are no upcoming dividends for Enveric Biosciences.

When is Enveric Biosciences (NASDAQ:ENVB) reporting earnings?

Enveric Biosciences’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Enveric Biosciences (ENVB) going to split?

There is no upcoming split for Enveric Biosciences.

What sector and industry does Enveric Biosciences (ENVB) operate in?

Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-